Isabella Premoli

Director - Translational Medicine Saniona

Seminars

Tuesday 1st December 2026
Implementing EEG & Digital Biomarkers for Neuropsychiatric Indications – Navigating Pharmacology Confirmation, At-Home Monitoring & Technology Selection
1:30 pm
  • Discover how EEG biomarkers confirm GABAergic pharmacology translationally from rodents to healthy volunteers, providing dose navigation and PK-PD relationships in Phase 1 studies, while understanding the critical limitation of clinical translation
  • Explore emerging at-home EEG technologies that enable remote data acquisition in psychiatric patient populations, addressing the operational challenges of implementing EEG in large Phase 2
  • Comparing vendor selection criteria when evaluating digital biomarker technologies for neuropsychiatric trials and balancing selecting technologies that deliver reproducible, interpretable results that satisfy both scientific rigor and operational feasibility
Isabella Premoli - Expert Speaker for Novel CNS Biomarkers Summit Europe